html5-img
1 / 15

Access to HIV/AIDS Medicines The 3x5 strategy

Access to HIV/AIDS Medicines The 3x5 strategy. WHO/EDM Technical Briefing Seminar 15-19 March 2004. Three by Five. The goal is universal access to anti-retroviral therapy as a human right The target is three million people on treatment by the end of 2005

cynthia-woodward
Télécharger la présentation

Access to HIV/AIDS Medicines The 3x5 strategy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Access to HIV/AIDS Medicines The 3x5 strategy WHO/EDM Technical Briefing Seminar 15-19 March 2004

  2. Three by Five • The goal is universal access to anti-retroviral therapy as a human right • The target is three million people on treatment by the end of 2005 • The treatment gap was declared a global health emergency Sept 22nd at UNGA

  3. Pillar 1: WHO and global level activities • 1. Visible WHO leadership and commitment to urgent action to reach the goal of universal access to ART • 2. Locate the rights-based 3x5 initiative within the broader development context • 3. Support all national efforts whilst focusing WHO resources on high-burden and strategic countries to achieve maximal impact of 3x5 initiative • 4. Align and mobilize partner support to achieve 3x5 target at global level Momentum created Country owned process Member States UNAIDS Co-sponsors Other partners

  4. Pillar 2: Country Support Efforts • 5. Secure the key elements required at the national level to deliver the 3x5 target as part of a comprehensive response to HIV/AIDS • 6. Strengthen and support the renewal of health systems and national operational capacity for scaling up ART programs • 7. Strengthen and build human capacity for scaling up ART • 8. Expand capacity of communities to be fully involved in ART program planning and delivery National Medicines Policy (Selection, procurement, regulation, supply chain management, rational use)

  5. Pillar 3: simplified, standardised tools • 9. Simplify and standardize procedures to identify individuals in need of therapy and facilitate entry to ART programs • 10. Simplify and standardize ARV therapy to facilitate adherence and enable rapid scale-up to be implemented • 11. Simplify and standardize tools for tracking ART program performance including drug resistance surveillance Rapid test based approach 4 First-line treatments FDCs and Blisters Standardized M&E Guidelines

  6. Pillar 4: Effective medicines and diagnostics supply • 12. Support country access to , and efficient distribution of high quality, low cost medicines and diagnostics

  7. Pillar 5: Success stories and learning by doing • 13. Build on success • 14. Continuously learn by doing - with ongoing evaluation and analysis of program performance and a focused operational research agenda.

  8. AMDS objectives • Ensure that the supply of quality commodities is never an obstacle to expanding treatment, care and support • Use improved commodity supply to catalyze rapid expansion of treatment, to promote equity, to support prevention

  9. AMDS general principles • Use partners to best capacity • Don’t develop new structures/systems • All partners involved in planning and further expansion • Support all available channels (government, NGOs, insurances)

  10. What the AMDS will doAssist/support a country-driven process…… • Create information hub • Bring together strategic information from existing sources (ensure ease of access) • Develop new tools as needed (self or contracted) • Serve as “one-stop-shop” for specific support • Initiate and act as gateway for information and Technical Assistance by partners inside and outside WHO • Support operational staff • (Recruit), train and support dedicated procurement and supply chain management staff

  11. What the AMDS does not plan to do……… • No procurement itselfbut • Support countries to buy/manage supplies • Direct to appropriate services • ARVs: PQ Procurement agencies • Diagnostics: WHO bulk procurement scheme • No repeat /duplicate effort • Use ongoing work, available expertise and information • No new structures MOH, NGO. • No funding to purchase commodities

  12. Examples of EDM action and guidance on Access to HIV-Related Medicines* • 13th WHO Model List of Essential Medicines, including (since 12th edition including ARVs) • 2nd WHO Model Formulary, including section on ARVs • Pre-qualification of HIV medicines and manufacturers (R&D and generic) • Annual Reports on “Sources and Prices of Selected Drugs and Diagnostics for People Living With HIV/AIDS; jointly with UNICEF, UNAIDS, MSF • Operational Principles for Good Pharmaceutical Procurement – IPC group • Globalization, TRIPS and Access to Pharmaceuticals. WHO Policy Perspectives on Medicines * Available on EDM web site (http://www.who.int/medicines/)

  13. For further information………. Peter Graaff graaffp@who.int

More Related